NCT04040205 2025-07-20Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationMedical College of WisconsinPhase 2 Recruiting44 enrolled
NCT00445965 2024-04-04Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerMemorial Sloan Kettering Cancer CenterPhase 2 Completed78 enrolled 11 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00062283 2013-06-26Alanosine in Treating Patients With CancerNational Cancer Institute (NCI)Phase 2 Completed